Clinicopathologic Evaluation of CD80, CD86, and PD-L1 Expressions with Immunohistochemical Methods in Malignant Melanoma Patients
Objective: Diagnostic and prognostic biomarkers for malignant melanoma are crucial for treatment and for developing targeted therapies. Malignant melanoma is a highly immunogenic tumor, and its regression, treatment, and prognostic evaluation are directly related to escape from immune destruction. T...
Saved in:
Main Authors: | Esra COBANKENT AYTEKIN (Author), Betul UNAL (Author), Cumhur Ibrahim BASSORGUN (Author), Ozlenen OZKAN (Author) |
---|---|
Format: | Book |
Published: |
Federation of Turkish Pathology Societies,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD80 and CD86 Costimulatory Molecules Differentially Regulate OT-II CD4+ T Lymphocyte Proliferation and Cytokine Response in Cocultures with Antigen-Presenting Cells Derived from Pregnant and Pseudopregnant Mice
by: Tomasz Maj, et al.
Published: (2014) -
Clinicopathological analysis of patients diagnosed with DRESS
by: Burçin Cansu Bozca, et al.
Published: (2023) -
Relationship Between PD-L1, PD-1, CD8 and Clinicopathological Factors in Primary SCCs
by: Preslav Vasilev, et al.
Published: (2024) -
Clinicopathological correlation of cancer stem cell markers Oct-4 and CD133 expression as prognostic factor in malignant lesions of gallbladder: An immunohistochemical study
by: Naseem Fatima, et al.
Published: (2019) -
Clinicopathological and Immunohistochemical Analysis of 21 cases of Traumatic Ulcerative Granuloma with Stromal Eosinophilia Using CD30, CD68 and TGF-β1
by: Mustafa B Al-Talqani, et al.
Published: (2018)